circle

A PIPELINE POWERED BYPASSION

PUBLICATIONS AND PRESENTATIONS

Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects

Clinical Drug Investigation
Trivedi A, Mackowski M, Jafarinasabian P, Zhang H, Flach S, Terminello B, Bhatia A, Dutta S, Lee E
June 10, 2021

Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Clinical Pharmacology in Drug Development
Trivedi A, Oberoi RK, Mackowski M, Jafarinasabian P, Zhang H, Flach S, Hutton S, Abbasi S, Dutta S, Lee E
June 9, 2021

Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects

Clinical Drug Investigation
Trivedi A, Oberoi RK, Jafarinasabian P, Zhang H, Spring M, Flach S, Abbasi S, Dutta S, Lee E
June 7, 2021

Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator

Biopharmaceutics & Drug Disposition
Trivedi A, Oberoi RK, Mackowski M, Jafarinasabian P, Zhang H, Flach S, Simiens M, Terminello B, Abbasi S, Dutta S, Lee E
June 4, 2021

Impact of Ejection Fraction on the Therapeutic Effect of Omecamtiv Mecarbil in Patients with Reduced Ejection Fraction: A Secondary Analysis from GALACTIC-HF

Presentation, American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)
Teerlink JR
Virtual
May 17, 2021